Department of Breast Surgery, The Royal Wolverhampton Hospitals NHS Trust, New Cross Hospital, Wednesfield Road, Wolverhampton WV10 0QP, UK.
Department of Breast Surgery, The Royal Wolverhampton Hospitals NHS Trust, New Cross Hospital, Wednesfield Road, Wolverhampton WV10 0QP, UK.
Eur J Surg Oncol. 2014 Apr;40(4):442-8. doi: 10.1016/j.ejso.2014.01.003. Epub 2014 Jan 22.
Skin reducing mastectomy, dermal sling and immediate implant reconstruction (SRMIR) is an emerging technique where, de-epithelialised inferior skin flap sutured to pectoralis major provides vascularised, dermal sling for the implant. We aimed to assess patient satisfaction following SRMIR and determine if radiotherapy affected patient reported outcomes.
A prospective database of women undergoing SRMIR was analysed. SRMIR was performed in 92 women (116 breasts). Radiotherapy was received by 45 women and it was not required in 47 women. Forty eight women had contralateral surgery: 21 breast reduction/mastopexy, 1 augmentation, 26 mastectomy/reconstruction. A validated breast evaluation questionnaire provided patient reported outcomes.
Median follow up was 20 months. Early complications were similar in both groups, but those in the radiotherapy group had a higher incidence of implant loss (6/45 = 13% vs 1/47 = 2%; p = 0.06) and grade III/IV capsular contracture (11/45 = 24% vs 6/47 = 13%; p = 0.20). The outcome questionnaire was sent to 83 women who were disease free and had retained their implants. Sixty three women responded (76%). Patient reported satisfaction was high, with or without radiotherapy. Women receiving radiotherapy gave lower scores, but it was statistically significant only for general appearance and symmetry.
Although complications after radiotherapy are higher in patients who had SRMIR, the majority of women who retained their implant are highly satisfied with their reconstruction. Majority of these patients were happy to recommend SRMIR procedure to their friend.
皮肤缩减乳房切除术、真皮吊带和即刻植入物重建(SRMIR)是一种新兴技术,其中去上皮化的下皮瓣缝合到胸大肌为植入物提供了血管化的真皮吊带。我们旨在评估 SRMIR 后的患者满意度,并确定放疗是否影响患者报告的结果。
对接受 SRMIR 的女性进行前瞻性数据库分析。92 名女性(116 只乳房)接受了 SRMIR。45 名女性接受了放疗,47 名女性不需要放疗。48 名女性接受了对侧手术:21 例乳房缩小/乳房提升术、1 例隆胸术、26 例乳房切除术/重建术。使用经过验证的乳房评估问卷提供了患者报告的结果。
中位随访时间为 20 个月。两组的早期并发症相似,但放疗组的植入物丢失发生率较高(6/45=13%比 1/47=2%;p=0.06),III/IV 级包膜挛缩发生率较高(11/45=24%比 6/47=13%;p=0.20)。调查问卷发送给了 83 名无病且保留了植入物的女性,其中 63 名女性(76%)做出了回应。有或没有放疗的女性报告满意度都很高。接受放疗的女性评分较低,但只有在一般外观和对称性方面具有统计学意义。
尽管接受 SRMIR 的患者放疗后并发症较高,但大多数保留植入物的女性对重建非常满意。大多数这些患者都很高兴向朋友推荐 SRMIR 手术。